<unk>  is a genetically engineered immunosuppressive drug sold under the brand name Amevive in Canada, the United States, and Australia. It is used to control inflammation in moderate to severe psoriasis with plaque formation, where it interferes with lymphocyte activation.
Alefacept
Glatiramer
Romiplostim
Lenograstim
Sargramostim
Lubeluzole
Riluzole
Catumaxomab